These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 30321778)

  • 21. Synthesis, α-amylase inhibitory potential and molecular docking study of indole derivatives.
    Taha M; Baharudin MS; Ismail NH; Imran S; Khan MN; Rahim F; Selvaraj M; Chigurupati S; Nawaz M; Qureshi F; Vijayabalan S
    Bioorg Chem; 2018 Oct; 80():36-42. PubMed ID: 29864686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A facile approach synthesis of benzoylaryl benzimidazole as potential α-amylase and α-glucosidase inhibitor with antioxidant activity.
    Aroua LM; Almuhaylan HR; Alminderej FM; Messaoudi S; Chigurupati S; Al-Mahmoud S; Mohammed HA
    Bioorg Chem; 2021 Sep; 114():105073. PubMed ID: 34153810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
    Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico molecular docking and in vitro antidiabetic studies of dihydropyrimido[4,5-a]acridin-2-amines.
    Bharathi A; Roopan SM; Vasavi CS; Munusami P; Gayathri GA; Gayathri M
    Biomed Res Int; 2014; 2014():971569. PubMed ID: 24991576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study.
    Adegboye AA; Khan KM; Salar U; Aboaba SA; Kanwal ; Chigurupati S; Fatima I; Taha M; Wadood A; Mohammad JI; Khan H; Perveen S
    Eur J Med Chem; 2018 Apr; 150():248-260. PubMed ID: 29533872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterocyclic compounds as a magic bullet for diabetes mellitus: a review.
    Farwa U; Raza MA
    RSC Adv; 2022 Aug; 12(35):22951-22973. PubMed ID: 36105949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, and facile synthesis of 1,3 diaryl-3-(arylamino)propan-1-one derivatives as the potential alpha-amylase inhibitors and antioxidants.
    Bashary R; Khatik GL
    Bioorg Chem; 2019 Feb; 82():156-162. PubMed ID: 30321778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review.
    Kaur N; Kumar V; Nayak SK; Wadhwa P; Kaur P; Sahu SK
    Chem Biol Drug Des; 2021 Oct; 98(4):539-560. PubMed ID: 34173346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of antidiabetic and antioxidant activities of medicinal plants.
    Shori AB
    J Integr Med; 2015 Sep; 13(5):297-305. PubMed ID: 26343100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Insight of Alpha-amylase Inhibitors as a Valuable Tool in the Management of Type 2 Diabetes Mellitus.
    Bashary R; Vyas M; Nayak SK; Suttee A; Verma S; Narang R; Khatik GL
    Curr Diabetes Rev; 2020; 16(2):117-136. PubMed ID: 31237215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes.
    Teng H; Chen L
    Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3438-3448. PubMed ID: 26854322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the synthesis and medicinal perspective of pyrazole-based α-amylase inhibitors as antidiabetic agents.
    Khator R; Monga V
    Future Med Chem; 2024 Jan; ():. PubMed ID: 38230638
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.